DiaMedica Therapeutics (DMAC) Tax Provisions (2018 - 2026)
DiaMedica Therapeutics (DMAC) reported Tax Provisions of $7000.0 for Q1 2026, up 16.67% on a YoY basis from $6000.0 in Q1 2025, and down 30.0% quarter-over-quarter from $10000.0 in Q4 2025.
DiaMedica Therapeutics (DMAC) Tax Provisions (2018 - 2026) Analysis & Trends
DiaMedica Therapeutics has reported Tax Provisions for 9 years, with the latest figure at $7000.0 in Q1 2026.
- For the quarter ending Q1 2026, Tax Provisions rose 16.67% year-over-year to $7000.0; the trailing twelve-month figure through Mar 2026 stood at $29000.0 (changed 0.0% YoY), and the FY2025 full-year result was $28000.0, down 6.67% from the prior year.
- Tax Provisions for Q1 2026 stood at $7000.0, down from $10000.0 in the prior quarter.
- The five-year high for Tax Provisions was $22000.0 in Q4 2023, with the low at $6000.0 in Q1 2025.
- Historically, Tax Provisions has averaged $8000.0 across 5 years, with a median of $7000.0 in 2022.
- Annual changes were most pronounced in 2023 — Tax Provisions soared 214.29% — and 2024, when it slumped 59.09%.
- DiaMedica Therapeutics' Tax Provisions stood at $7000.0 in 2022, then soared by 214.29% to $22000.0 in 2023, then tumbled by 59.09% to $9000.0 in 2024, then rose by 11.11% to $10000.0 in 2025, then fell by 30.0% to $7000.0 in 2026.
- The last three Tax Provisions figures came in at $7000.0 (Q1 2026), $10000.0 (Q4 2025), and $6000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | -11.20 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | -859,000.00 |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | 216,000.00 |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 221.50 Mn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | - |
| 10 | DiaMedica Therapeutics | 285.11 Mn | 233.77 Mn | - | 7,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7,000.00 |
| Dec 31, 2025 | 10,000.00 |
| Sep 30, 2025 | 6,000.00 |
| Jun 30, 2025 | 6,000.00 |
| Mar 31, 2025 | 6,000.00 |
| Dec 31, 2024 | 9,000.00 |
| Sep 30, 2024 | 7,000.00 |
| Jun 30, 2024 | 7,000.00 |
| Mar 31, 2024 | 7,000.00 |
| Dec 31, 2023 | 22,000.00 |
| Sep 30, 2023 | 7,000.00 |
| Jun 30, 2023 | 7,000.00 |
| Mar 31, 2023 | 7,000.00 |
| Dec 31, 2022 | 7,000.00 |
| Sep 30, 2022 | 7,000.00 |
| Jun 30, 2022 | 7,000.00 |
| Mar 31, 2022 | 7,000.00 |
| Dec 31, 2021 | 7,000.00 |
| Sep 30, 2021 | 7,000.00 |
| Jun 30, 2021 | 7,000.00 |